Market Tracker

04/17 5:16pm ET

Incyte Corp (NASDAQ:INCY)

During the Trading Day
44.54 +0.56 / +1.27%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
44.53 -0.0092 / -0.02%
 
Volume: 251.8K

Today’s Trading

Previous close43.98
Today’s open43.95
Day’s range42.94 - 46.15
Volume3,681,855
Average volume (3 months)2,166,880
Market cap$7.8B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+17.55%
Earnings growth (next 5 years)+83.94%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+0.09+0.07%
RDYDr.Reddy's Laborator...0.000.00%
HSPHospira Inc-0.16-0.37%
PCYCPharmacyclics Inc-0.29-0.32%
Data as of 4:01pm ET, 04/17/2014

Financials

Next reporting dateMay 8, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David C. Hastings
Corporate headquarters
Wilmington, Delaware

Forecasts